Kyung Eui Park

Title: The Innovations of Kyung Eui Park

Introduction

Kyung Eui Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on triazolopyrazine derivatives. His research focuses on developing compositions and methods that enhance the treatment of various hyperproliferative disorders.

Latest Patents

Kyung Eui Park holds a patent for "Maleate salts of triazolopyrazine derivatives, compositions, methods of use, and processes of manufacturing the same." This patent describes pharmaceutical compositions that exhibit improved storage stability and pharmacokinetic properties. The maleate salts of triazolopyrazine derivatives are designed to bind competitively to the phosphorylation site of c-MET kinase, offering potential therapeutic benefits.

Career Highlights

Kyung Eui Park is associated with Abion Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in treating various medical conditions.

Collaborations

He collaborates with talented individuals such as Jun Young Choi and Yeong Mun Kim, contributing to a dynamic research environment that fosters innovation.

Conclusion

Kyung Eui Park's contributions to pharmaceutical sciences through his innovative patents highlight the importance of research in developing effective treatments. His work exemplifies the impact of dedicated inventors in advancing healthcare solutions.